SciCombinator

Discover the most talked about and latest scientific content & concepts.

M Zhuo, H Chen, T Zhang, X Yang, J Zhong, Y Wang, T An, M Wu, Z Wang, J Huang and J Zhao
Abstract
The PD-L1 antibody atezolizumab has shown promising efficacy in patients with advanced non-small cell lung cancer. But the predictive marker of clinical benefit has not been identified.
Tweets*
0
Facebook likes*
0
Reddit*
0
News coverage*
0
Blogs*
0
SC clicks
0
Concepts
-
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com